Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.

BMC cancer - 4 Dec 2019

Hao Zhaonian, Guo Dongsheng

Abstract excerpt

BACKGROUND: Glioma is one of the most common type of primary central nervous system tumors. EGFR mutation, a common alteration occurs in various tumors, is not brought to the forefront in understanding and treating glioma at present. METHODS: In the present study, we demonstrated an immune infiltration related pattern of EGFR mutation in lower-grade glioma. In silico analyses were performed to investigate EGFR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Central Nervous System Neoplasms
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Programmed Cell Death 1 Receptor

Share to Protein Interaction Mapping

Share to Survival Analysis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 31801484
DOI: 10.1186/s12885-019-6384-8
PMCID: PMC6894128

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.PMID 31801484Read ↗

EGFR mutation: a prognostic factor associated with immune infiltration in lower-grade glioma.Semantic proximity Read ↗

Identification of molecular subtypes based on inflammatory response in lower-grade gliomaSemantic proximity Read ↗

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade GliomaSemantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

Development of a prognostic model of glioma based on immune‑related genesSemantic proximity Read ↗

The Expression and Prognostic Values of Epidermal Growth Factor Receptor Family in GliomaSemantic proximity Read ↗

Development and Validation of a Novel Prognostic Model for Glioma Based on Immune-Related GenesSemantic proximity Read ↗

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapySemantic proximity Read ↗

Association Between Tumor Mutation Burden and Prognosis in Lower-Grade Glioma: An Exploratory Study Semantic proximity Read ↗

Development of a tumor microenvironment-related prognostic signature in glioma to predict immune landscape and potential therapeutic drugs.Semantic proximity Read ↗

Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.